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Abstract. Over the last decades Nanotechnology has promised to advance science 
and technology in many areas. Within medicine, nanomedicine promises to deliver 
new methods for diagnosis, prognosis and therapy. As the amount of available 
information is rapidly growing, new Biomedical Informatics approaches have to be 
developed to satisfy the increasing demand on data and knowledge management. 
In 2007, a new subdiscipline, already named “Nanoinformatics”, has been created 
with support from the US National Science Foundation. In Europe, a project 
named ACTION Grid has been launched with support from the European 
Commission to analyze challenges and agenda for developing Nanoinformatics as 
a discipline related to Nanotechnology, Bio-medicine and Informatics. For MIE 
2009, members of this consortium proposed a Workshop to discuss the scientific 
and strategic issues associated to this topic. Nanoinformatics aims to create a 
bridge between nanomedicine and information technology applying computational 
methods to manage the information created in the nanomedical domain. 
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Introduction 
Nanotechnology aims to advance the formulation of materials and manufacture of 
devices by controlling matter at the scale of 1-100 nanometers. The novel properties of 
the resulted nano-materials and the induced phenomena could be exploited towards 
significant medical applications, such as for the diagnosis and therapy of diseases, in an 
already established discipline named Nanomedicine. A new discipline, 
Nanoinformatics, is currently being developed in parallel to address the informatics 
needs of Nanomedicine. From a Biomedical Informatics, it could be the continuation of 
Biomedical Informatics at the atom level, opening a significant range of applications 
and scientific research. In such direction, authors of this paper have proposed a 
Workshops to be carried out at the MIE 2009 conference, where all these issues could 
be discussed. This continues efforts already launched by the European Commission and 
the US National Science Foundation. 
 
 
 
1. Nanomedicine 
As nanomedicine begins to define itself, new interesting research directions are opened 
to the scientific community. Examples of the possibilities of nanomedicine are the 
achievement of non-damaging observation and diagnostic modalities or nano-devices 
and innovative tools for understanding cell mechanisms or differences between normal 
and abnormal physiological states. Nanodevices allow the analysis (on high sensitivity 
levels) of relatively small sample volumes enabling the acquisition and manipulation of 
cellular parameters (regarding cellular mechanics, morphology, and cytoskeleton), 
which have been hard to achieve using conventional technology [1]. 
 
 
 Fig 1. A representation of different aspects of Nanomedicine [2] 
 
Nanomedicine can bring to such aspects of diagnosis, prognosis and treatment 
processes results that traditional medicine could not even foresee. Complex molecules 
that seek out diseased or cancerous cells, sensors for diagnosing diseased states or 
replacement therapy may open new horizons for medicine. 
 
 
 
2. Nanoparticles in medicine 
Nanoparticles and nanomaterials are built as biodetection agents for DNA and proteins. 
In addition, nanodevices, such as nanowires and nanotubes, can be combined with 
nanoarrays to create automated nanodetection platforms. The MeSH term “nanoparticle” was 
introduced in 
2007, described as follows: “Nanometer-sized particles that are nanoscale in three 
dimensions. Term nanoparticle is 
subordinated to term nanostructure and superordinated to several terms: Dendrimers, Metal 
Nanoparticles, 
Nanocapsules, Nanosphere and Quantum Dots”[3]. 
 
 
 
 
Fig 2. “Nanostructures” in MeSH 
 
 
All these kinds of nanoparticles can be used in nanomedicine for different 
purposes. Dendrimers and nanospheres can be used as drug carriers or Quantum Dots 
can be used as marker for diagnosis and monitoring tasks. In general we can anticipate 
that nanoparticles will have a primary role in medical research within the next decades. 
However, the scientific community also faces some questions about patient safety 
and other possible secondary effects, such as those related to the use of nanoparticles. 
Studies on possible risks for human health due to the use of nanoparticles are currently 
obtaining an increasing interest. Nanoparticles can be of natural or biological origin, 
―like viruses―, and engineered ―i.e. of nonbiological origin. Viruses can be more or 
less invasive, and can cause serious health problems in human, animals or plants, in 
many cases more serious than bacterial organisms do. However, it can be argued that 
the non biological nanoparticles may produce similar or even greater damages. If this 
happened, how to handle them? 
The new area of Nanotoxicology wants to answer questions like those mentioned 
above. Research in this direction will be fundamental to ensure safe uses of 
nanoparticle-based medical products. To carry out experiments, new models of clinical 
trials will be needed. For all these issues, medical information will have to be linked to 
these experiments. In this direction, Nanoinformatics may play a significant role. 
 
 
 
 
3. Nanoinformatics 
Nanoinformatics is a new discipline that has grown exponentially over the last year, 
showing an interest in the computational aspects related to Nanotecnology and, 
obviously, Nanomedicine. Nanoinformatics can be seen as the extension of Biomedical 
Informatics at the atomic scale ―although there are singularities that need to be 
analyzed. 
Nanoinformatics describes the application of computer technology, information 
science and molecular simulations to organize, interpret, and predict the structure and 
physico-chemical properties of nanoparticules and nanomaterials. While 
Bioinformatics is usually applied in the context of analyzing DNA sequence data, 
Nanoinformatics is applied in the context of characterizing particles and materials with 
application in nano and biotechnology. A nanoinformatics key issue is the linkage of 
information, data, results and findings acquired using nano-related processes with the 
standard clinical procedures. This task will be fundamental for the future evolutions of 
the medical area. 
Figure 3 shows below an example of such extended vision of Biomedical 
Informatics towards the Nano level, into this area of Nanoinformatics. During the last 
decade there have been many efforts to link the classical areas of Medical Informatics 
and Bioinformatics. This effort has been boosted by results from various genomic 
projects, producing 1000+ databases with “-omics” data that are currently used for 
research. The areas of genomic and personalized medicine and translational 
bioinformatics, which aims to transfer results of basic research to different new 
direction in medicine are good examples of such synergy. Meanwhile, the “Nano” level 
opens up new directions and challenges, for basic and applied research, that should be 
thoroughly discussed. The workshop at the MIE 2009 plans to directly analyse these 
questions and their particular relevance for the Biomedical Informatics Agenda. 
 
 
 
 
Figure 3. Biomedical informatics going down to the atom level, towards 
Nanoinformatics. (extracted from [4]) 
 
 
4. The ACTION-Grid project 
ACTION-Grid [5] is a project that aims to establish the basis for a dialogue among 
researchers in Medical Informatics, Bioinformatics and Nanoinformatics. The project 
involves countries belonging to four different geographic areas: Europe, The Western 
Balkans, Latin America and North Africa. 
One of ACTION-Grid’s main goals is to provide information about the 
informational resources used and created by professional researchers in the disciplines 
mentioned before. By sharing this information, the scientific community can 
collaboratively develop better databases, tools or services (in general “resources) that 
others already created and that can be used by others researchers. 
A second important objective of the project is to identify the most relevant 
research directions in Medical Informatics, Bioinformatics and Nanoinformatics. The 
results of this task will be used by the European Commission as a roadmap for future 
project Calls. 
At the same time, partners of the ACTION-Grid project are currently working on 
different Nanoinformatics initiatives such as: 
- Develop a method for the automatic creation and update of the resource index 
mentioned before [6] 
- Research on Micro and Nano arrays 
- Studies on Lab-on-Chip technologies [7] 
- Adaptation of knowledge management systems to the nanomedicine context 
[8] 
- A database of nanoparticles for national agencies 
 
 
 
 
 
 
 
 
 
 
 
5. Conclusions 
Nanoinformatics represents a new stage in the Biomedical Informatics area. While 
knowledge about nanotechnology is constantly increasing, the importance of the 
synergy between “nano” and “info” domains is just beginning. Thus, it is fundamental 
for the scientific community to work on the analysis and the development of the 
potentialities of this discipline. For Biomedical Informatics professionals, there will be 
a large number of issues to be discussed and addressed in the next decades. These 
issues could lead to open up complete new areas of research and development. 
This proposal, summarizing in part previous documents and work carried out by 
ACTION-Grid members, aims to invite researchers to discuss these issues in an open 
workshop at the MIE 2009 conference. In this event researchers will discuss scientific 
and technological challenges in the area and proposals for future work at the European 
level. Similar initiatives have recently begun with support by important national and 
international organizations [9, 10, 11]. 
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